A malaria vaccine study in healthy adults
Part of Infections clinical trials.
This trial tests a new malaria vaccine in healthy adults. It's an early (Phase 1) study, so it's mainly checking safety and how the body responds to the vaccine, not whether it prevents malaria yet.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult aged 18 to 50.
- Have a body mass index (BMI) between 18 and 35. (BMI is a measure of body size based on height and weight.)
- If you can become pregnant, you must not be pregnant or breastfeeding, and must use reliable birth control during the study.
- Never have had malaria, and avoid traveling to malaria areas during the study.
- Not have a weak immune system (e.g., from HIV, or taking immunosuppressant drugs).
- Not have taken certain medications (like painkillers or allergy meds) within 24 hours of vaccination.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new malaria vaccine in healthy Thai adults. Participants will receive the vaccine and then be exposed to malaria in a controlled setting to see if the vaccine protects them. If you qualify, you'll be closely monitored and treated.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
This study tests an experimental malaria vaccine in healthy adults. The vaccine is given along with other medicines and a controlled exposure to mosquito bites to see how well it protects against malaria.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
This study tests a new malaria vaccine to see if it is safe and how the body responds. It involves healthy adults in Burkina Faso who will be monitored closely after vaccination.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Hear when a new Malaria Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.